GLP1R and type 2 diabetes mellitus: Glucagon-like peptide-1 (GLP-1) receptor agonists, such as exenatide and liraglutide, which are incretin hormones, have become established as an important therapeutic option in the management of patients with type 2 diabetes [1,3].